Nitrogen dioxide (NO 2 ) is a common indoor and outdoor air pollutant that may induce deterioration of respiratory health. In this study the effects of repeated daily exposure to NO 2 on airway antioxidant status, inflammatory cell and mediator responses, and lung function were examined. Healthy nonsmoking subjects were exposed under controlled conditions to air (once) and to 2 ppm of NO 2 for 4 h on four consecutive days. Lung function measurements were made before and immediately after the end of each exposure. Bronchoscopy with endobronchial biopsies, bronchial wash (BW), and bronchoalveolar lavage (BAL) was carried out 1.5 h after the air exposure and after the last exposure to NO 2 . Repeated NO 2 exposure resulted in a decrease in neutrophil numbers in the bronchial epithelium. The BW revealed a twofold increase in content of neutrophils (p Ͻ 0.05) and a 1.5-fold increase in myeloperoxidase (MPO) (p Ͻ 0.01) indicative of both migration and activation of neutrophils in the airways. After the fourth NO 2 exposure, antioxidant status of the airway fluid was unchanged. Significant decrements in FEV 1 and FVC were found after the first exposure to NO 2 , but these attenuated with repeated exposures. Together, these data indicate that four sequential exposures to NO 2 result in a persistent neutrophilic inflammation in the airways, whereas changes in pulmonary function and airway antioxidants are resolved. We conclude that NO 2 is a proinflammatory air pollutant under conditions of repeated exposure. Blomberg A, Krishna MT, Helleday R, Söder-berg M, Ledin M-C, Kelly FJ, Frew AJ, Holgate ST, Sandström T. Persistent airway inflammation but accommodated antioxidant and lung function responses after repeated daily exposure to nitrogen dioxide.
Nitrogen dioxide (NO 2 ) is an air pollutant of concern since numerous epidemiologic studies have indicated an increase in respiratory illness in people exposed to NO 2 in polluted ambient air (1, 2) . There are also data suggesting an increased susceptibility to airway infection because of NO 2 exposure (3) (4) (5) . NO 2 is one of the most common air pollutants in ambient air, in indoor air in some industrial workplaces, and in homes with gas stoves, where 24-h averages may reach 0.5 ppm and peak concentrations 1 to 2 ppm (1, 6) . Exposure to NO 2 concentrations of 2 ppm or more may be encountered in workplaces such as ferries, Ro-Ro ships, mines, and tunnels (7) (8) (9) . In mine environments the mean annual NO 2 concentration may be as high as 1.7 ppm, with 10% of the daily mean values above or equal to 3 ppm and short-term exposure values of as much as 8 ppm (10, 11) .
Occasional studies have demonstrated bronchoconstriction after a single exposure to 1.5 to 5 ppm of NO 2 in healthy subjects, whereas some have been unable to detect an effect despite an exposure concentration as high as 4 ppm (12) . Folinsbee (13) , in a recent meta-analysis, estimated bronchial hyperresponsiveness to increase after exposure to NO 2 at concentrations above 1 ppm. To date, the effects of repeated exposure to NO 2 on lung function have been addressed in only one study. Rubinstein and coworkers (14) in San Francisco investigated five healthy subjects exposed to 0.6 ppm on four occasions within 6 d, but they were unable to detect any lung function change after the exposure series. The paucity of data in this respect is most likely due to the laborsome study designs needed to elucidate effects of multiple-day exposures.
It is well recognized that exposure to NO 2 causes an inflammatory response in the airways. We recently reported that a single exposure to 2 ppm of NO 2 for 4 h resulted in an increase in interleukin (IL)-8 (1.5 h) and neutrophils (6 h) in the proximal airways of normal healthy subjects, but no signs of inflammatory cell changes were detected in bronchial biopsies (15) .
A single, acute exposure to NO 2 has also been shown to transiently modify the protective antioxidant defense network in the respiratory tract lining fluid with consumption of ascorbic acid (AH 2 ) and uric acid (UA) and increased reduced glutathione (GSH) levels (16) . Previous studies evaluating the inflammatory effects of repeated exposure to NO 2 have revealed different effects compared with a single acute exposure. Repeated exposure to 1.5 or 4 ppm of NO 2 for 20 min every second day on six occasions resulted in decreased CD16 ϩ 56 ϩ and CD19 ϩ cells in bronchoalveolar lavage (BAL), 24 h after the final exposure. In contrast, neutrophils, mast cells, and total lymphocytes were unaffected (17, 18) . The soluble mediators hyaluronan (HA) and myeloperoxidase (MPO) increased, whereas methyl-histamine content decreased. The levels of fibronectin, tryptase, albumin, total protein, leukotriene B 4 (LTB 4 ), PGE 2 , and PGF 2 ␣ were all unaffected (19) . Repeated exposure to a low (0.6 ppm) NO 2 concentration induced a slightly greater proportion of natural killer (NK)-cells in BAL as early as 2 h after the last of four NO 2 exposures (14) .
The aim of the present study was to evaluate the effects of repeated NO 2 exposure on four consecutive days on cells, inflammatory markers, and antioxidants in the bronchial and bronchoalveolar regions of the lung. In addition, bronchial biopsies were taken to assess whether repeated exposure to NO 2 would induce an inflammatory response in the bronchial mucosa. Furthermore, lung function was followed to determine whether bronchoconstriction occurred and whether this was modified on subsequent exposure days.
METHODS

Subjects
Twelve healthy, nonsmoking volunteers (eight male and 4 female; mean age, 26 yr; range, 21 to 32 yr) without any history of asthma or other respiratory disease were recruited. All had negative skin prick tests and normal lung function (FEV 1 and FVC Ͼ 80% of predicted). No subject had a history of airway infection for at least 6 wk prior to the first exposure or during the study. No nonsteroid anti-inflammatory drugs (NSAIDs) or aspirin or additional intake of vitamin C (ascorbic acid) and vitamin E ( ␣ -tocopherol) were allowed.
Study Design
The subjects were exposed once to filtered air and on four consecutive days to air containing 2 ppm of NO 2 in an environmental chamber according to a previously described standard protocol (20, 21) . During the exposures light exercise (75 W) on a bicycle ergometer was alternated with rest in 15-min intervals. Each exposure lasted for 4 h. The air exposure and the four exposures to NO 2 were performed in random order, separated by at least 3 wk. Flexible fiberoptic bronchoscopy with mucosal biopsies, bronchial wash (BW), and BAL was performed 1.5 h after the air exposure and the fourth and last NO 2 exposure, and it has been described elsewhere (15) . In this study, the effects on the airways of four daily exposures to 2 ppm of NO 2 were compared with results achieved after a single air exposure. A doubleblinded randomized study with four air exposures as well as the four conducted NO 2 exposures would have been optimal, but it was not possible because of practical reasons and resources. Ideally, the NO 2 -induced effects on airway reactivity during the repeated exposure series should also have been addressed in this study. This was not possible, however, since the bronchial provocation tests may elicit airway inflammation themselves and, hence, influence the inflammatory markers (22, 23) . Informed consent was obtained from the subjects, and the study was approved by the Ethics Committee of Umeå University.
Nitrogen Dioxide Exposure
The exposures were performed at the Medical Division of the National Institute for Working Life at Umeå according to the principles previously described (17, 18, 20, 21, 24) and the NO 2 exposure technique has been presented elsewhere (16) . In short, the exposures were performed in an exposure chamber built of aluminum. Windows and an intercommunication system enable the operator to maintain visual contact and communication with the subject inside the chamber. The concentration of NO 2 within the chamber was continuously monitored and registered. During this exposure series the chamber air temperature was kept at 20.0 Ϯ 0.5 Њ C, and the relative humidity was 50.1 Ϯ 1.0%. During the NO 2 exposures the NO 2 concentration was 2.0 Ϯ 0.16 ppm.
Lung Function Assessments
The dynamic spirometry variables (FVC and FEV 1 ) were measured before and immediately after each exposure using a whole-body plethysmograph with SensorMedics 2100 system (SensorMedics Autobox 2800; SensorMedics, Yorba Linda, CA). At least three satisfactorily performed well-cooperated measurements of each variable were performed as judged by an experienced lung function technician and according to the guidelines of the American Thoracic Society (25) .
Bronchoscopies
Fiberoptic bronchoscopy was performed as previously described (15, 16, 26) . In short, lidocaine was used for topical anesthesia and mild sedation was achieved with propofol given intravenously. The bronchoscope was inserted through the mouth with the subject in supine position. At each of the two bronchoscopies three endobronchial mucosal biopsies were taken using fenestrated forceps (FB-21C; Olympus, Tokyo, Japan) either from the anterior aspect of the main carina and the subcarinae of the third and fourth generation airways of the right side or from the posterior aspect of the main carina and the corresponding subcarinae on the left side, with lavages undertaken on the contralateral side, in a predetermined randomized way. The alternative locations were used during the second bronchoscopy to avoid biopsy artefacts at former biopsy sites. A bronchial wash with 2 ϫ 20 ml and a BAL with 3 ϫ 60 ml sterile phosphate-buffered saline (PBS) at pH 7.3 and 37 Њ C were performed and the fluid was gently withdrawn into a siliconized container placed in iced water.
The chilled lavage fluid was filtered through a nylon filter (pore diameter, 100 m; Syntab Product AB, Malmö, Sweden) and centrifuged at 400 ϫ g for 15 min. The supernatants were separated from the cell pellets, immediately analyzed for albumin and protein, and stored at Ϫ 70 Њ C until subsequent cytokine and mediator analyses. The cell preparations, including flow cytometry, were performed as previously outlined (15) . The following antibodies were used for flow cytometry; CD3, CD4, and CD8 receptors on T-cells, CD19 for B-cells, CD25 as a marker for IL-2 receptor, CD16 together with CD56 for natural killer cells, CD45RO for memory T-cells, CD69 as an activation marker for mononuclear cells, and HLA-DR as an activation marker for macrophages (Becton-Dickinson AB, Stockholm, Sweden). Albumin and total protein were measured with assays from Boehringer Mannheim (Mannheim, Germany) in an autoanalyzer at the Department of Clinical Chemistry, University Hospital of Northern Sweden, Umeå, Sweden. IL-8 was measured using a commercially available enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Inc., Minneapolis, MN). MPO, HA, and methyl-histamine (M-his) were analyzed by radioimmunoassay (RIA) (Kabi Pharmacia Diagnostics, Uppsala, Sweden).
The recovery from the first 20 ml BW and the first 10 ml of the instilled second 20 ml were analyzed separately, and the recovery from the 3 ϫ 60 ml was pooled. Cell differential counts, total protein, albumin, MPO, and HA concentrations were determined in the first BW and in the BAL. IL-8 was measured in the first BW, whereas flow cytometry was performed only on cells recovered from the BAL fluid since the cell number recovered by the first BW was too small for this analysis. Antioxidant concentrations were determined in both the second BW and the BAL.
Determination of Antioxidants
The methods used for the determination of these moieties in lavage fluid have been described in detail previously (16) . Reduced and oxidized glutathione were determined using the enzyme recycling method of Teitze, adapted for use on a plate reader (27) . UA and AH 2 were determined using reverse phase HPLC with electrochemical detection (16) .
Processing and Quantification of Bronchial Mucosal Biopsies
The bronchial biopsies were placed in ice-cooled acetone containing protease inhibitors and processed in glycolmethacrylate (GMA) resin as previously outlined (28) . The blocks were stored in airtight containers at Ϫ 20 Њ C until used for immunostaining. Sections were cut and stained with monoclonal antibodies as previously described (15) . In short, sections were cut at 2 m thickness and treated to block endogenous peroxide, and nonspecific antibody binding was blocked with undiluted culture supernatant. The primary monoclonal antibodies (mAbs) ( Table 1) were added and incubated at room temperature overnight. After rinsing, biotinylated rabbit antimouse IgG Fab (Dako, High Wycombe, UK) was applied followed by the streptavidin-biotinhorseradish-peroxide complex. Finally, the stained areas were developed with aminoethyl carbazole (AEC) in acetate buffer and hydrogen peroxide to yield a red color. The sections were then counterstained with Mayer's hematoxylin.
The expression of the endothelial adhesion molecules in the submucosal blood vessels was quantified by expressing the number of vessels staining with specific antiadhesion mAb as a proportion of the total vessel complement revealed by staining with the panendothelial mAb EN4, as previously described (29) . Immunostained inflammatory cells were counted separately in the epithelium and in the submucosa, the total number of positive cells being expressed as cells/mm of the epithelium and cells/mm 2 of the submucosa, respectively. Immunostaining was identified under the light microscope, and the length of the basement membrane and the area of the submucosa were measured using computer-assisted image analysis Colour Vision Software (Improvision, Birmingham, UK). Smooth muscle, glands, large blood vessels, and torn or folded tissue within the sections were not included in the areas analyzed.
Blood Samples
The peripheral blood samples were drawn prior to the bronchoscopies. Analyses of blood cells and differential counts were performed with an autoanalyzer at the Department of Clinical Chemistry, University Hospital of Northern Sweden, Umeå, according to clinical routine.
Statistics
In all analyses, each subject acted as his or her own control for comparisons after air and the last NO 2 exposure. As the exposure sequence was randomized, no period effect was expected. The sample size calculation was based on our previous experience in similar studies (15, (17) (18) (19) . The following parameters were defined a priori as primary end points: neutrophil counts in biopsies and BW, concentration of MPO and HA in BW, and the percentage of NK-cells in BAL. Other end points were included in order not to overlook other possible effects by the NO 2 exposures. These parameters were selected depending on their biologic plausibility to be affected by NO 2 . As the study design was very laborsome and resource demanding, it was not possible to design a series of studies each investigating a limited number of primary end points. The magnitude of the NO 2 effects on secondary parameters in BAL and biopsies was not corrected for multiple tests used, as this has been the practice in this Journal (15, 30) . Instead, any changes in these parameters were interpreted cautiously. Wilcoxon's nonparametric signed-rank test for paired observations was used as a conservative test for changes in BAL and biopsy data. Such data are not normally distributed within the size of the cohort investigated. Lung function data were analyzed with Shapiro-Wilk test for normality together with paired t test and analysis of variance. Statistical analyses were carried out with SPSS version 6.1.2 for Windows (SPSS, Inc., Chicago, IL). A p value Ͻ 0.05 was considered significant.
RESULTS
Immunohistochemistry
When analyzing the bronchial biopsy sections with neutrophil elastase and mast cell tryptase, cytoplasmic staining was observed, whereas ring staining was seen for CD3 ϩ , CD4 ϩ , and CD8 ϩ . The number of neutrophils in the epithelium showed a significant decrease after NO 2 compared with after air exposure (1.19, 0.40 to 2.97 versus 0.00, 0.00 to 0.70) (median, interquartile range) (p Ͻ 0.05). No other changes in the number of inflammatory cells were detected in the epithelium or submucosa. Expression of intercellular adhesion molecule-1 (ICAM-1) was also unchanged after the NO 2 exposures (Table 2) .
Cell Parameters in BW and BAL
Lavage recoveries after air exposure were: BW I, 6.5 ml (5.0 to 8.6); BW II, 10.0 ml (10.0 to 10.0); BAL, 132 ml (120 to 135), respectively. The amounts recovered after NO 2 exposure did not differ significantly. The total number of neutrophils increased in BW after repeated NO 2 exposure compared with after air exposure (0.80, 0.30 to 1.40 versus 1.54, 0.49 to 2.79) (p Ͻ 0.05). In BAL, no significant changes in total cell numbers and differential counts were found after repeated NO 2 exposure (Table 3 
Soluble Mediators and Cytokines
An increase in MPO (p Ͻ 0.01) and a decrease in albumin (p Ͻ 0.05) together with a trend towards a decrease in total protein (p ϭ 0.07) were found in BW after repeated NO 2 exposure. No changes were found in the concentrations of IL-8, HA, and methyl-histamine. In BAL fluid, no significant changes were detected in any of the measured soluble components (Table 4 ).
Antioxidants
No difference in the antioxidant status of either the BW or the BAL fluids were found after the four exposures to NO 2 compared with air (Table 5 ).
Blood Parameters
Total white cell number and differential counts were all unchanged after the last NO 2 exposure compared with after air (data not shown). 
Lung Function Measurements
The FEV 1 and FVC values before and after air exposure and the four exposures to NO 2 are presented in Table 6 . Differences between the preexposure and postexposure lung function values after each NO 2 exposure were compared with the difference after air exposure (Figure 1) . The data were shown to be drawn from a parametric population and thus allowing the use of a paired t test. There were no changes in preexposure FEV 1 
DISCUSSION
This study has demonstrated that four consecutive daily exposures to 2 ppm of NO 2 induce a neutrophilic airway inflammation in the bronchial wash. No evidence was, however, obtained of a parallel increase in inflammatory cell numbers in mucosal biopsy specimens from the proximal airways. Instead there were signs of migration of neutrophils from the epithelium into the airway lumen. The acute decrement in lung function that occurred over the first exposure to NO 2 was found to be attenuated during the subsequent exposures. Similarly, the initial loss of antioxidants in BAL that followed acute exposure to NO 2 (16) is resolved after multiple daily exposures. Taken together, these data indicate that although the acute effects on lung function and antioxidants were attenuated with repeated exposure there were still signs of an ongoing neutrophilic inflammation in the airways.
In agreement with findings from the single exposure of normal subjects to 2 ppm of NO 2 , four consecutive daily exposures to NO 2 did not result in inflammatory cell recruitment into the bronchial mucosa in the major airways (15) . Likewise, as after single exposure, the expression of ICAM-1 was unchanged after repeated exposure to 2 ppm of NO 2 , indicating that a major transit of cells at the sampled bronchial mucosal sites was unlikely to have occurred. Surprisingly, neutrophils present in the epithelium after air exposure had largely disappeared after the repeated exposures to NO 2 , suggesting that these cells had migrated from the epithelium into the airway lumen. Repeated NO 2 exposure may have initiated stimuli that directed neutrophils to migrate from the bronchial epithelium, the first cell surface to encounter the inhaled NO 2 .
A small volume BW is believed to better identify inflammation in the airways than a large volume BAL, which may more reflect conditions in the alveoli (31) . In a previous study we found an early increase in the C-X-C chemokine IL-8 in BW after a single exposure to NO 2 and we suggested that IL-8 could be an important chemoattractant for recruiting neutrophils after exposure to NO 2 (15) . In the present study, IL-8 was not elevated in BW after the fourth NO 2 exposure. This was probably due to attenuation by repeated exposure. The neutrophilia in the BW was accompanied by an increase in MPO, indicating that the neutrophils were activated by NO 2 . The current data, as well as recent lavage findings (32), suggest that repeated exposure to a relatively high concentration of NO 2 on four consecutive days results in airway inflammatory changes that are mainly located more peripherally in the airways than it is possible to biopsy. The major site for the NO 2 -induced inflammatory changes has been suggested to be the terminal bronchioles (33) , which here may be reflected in the finding of increased neutrophil numbers in the BW. Interestingly, however, repeated exposure to NO 2 also seems to effect the more proximal bronchi where migration of neutrophils into the airway lumen appears to be initiated.
In contrast to the findings after a single exposure to NO 2 , where consumption of AH 2 and UA together with an increase in GSH levels were demonstrated in airway lavage (16) , no changes in the concentration of these antioxidants were seen after repeated NO 2 exposure. Hence, it is likely that the exposure burden used in this study induced counter regulatory mechanisms that attenuated the immediate effects seen after a single NO 2 exposure. There mechanisms are presently unclear but may include replenishment of lost antioxidants in the epithelial lining fluid, and/or the upregulation of other defenses, which may limit oxidative stress in the airways.
In the present study we used a different study design than that employed in our previous repeated exposure studies in which short, 20-min exposures were repeated every second day (17) (18) (19) . The intervals between, and the duration of, the exposures are likely to be important determinants of the induction of counter regulatory defense mechanisms in the airways. These mechanisms may not be elicited when subjects are exposed for short periods at longer intervals (i.e., 20 min every other day). A difference between the responses after daily exposures compared to alternate-day exposures was therefore not unexpected. The effects on lymphocyte subsets seen in previous human and animal studies of repeated NO 2 exposure (14, 17, 18, 34) were not detected in the present study with four daily exposures. The time point for bronchoscopy is probably another important consideration when evaluating the effects of repeated exposure to NO 2 . Rubinstein and colleagues (14) found a slight increase in the percentage of NK-cells in BAL 2 h after the last of four 2-h exposures to 0.60 ppm of NO 2 within 6 d. Our BAL data showed no effects on NK-cells, but a small, yet significant, increase in CD25ϩ lymphocytes was seen after the repeated NO 2 exposures, indicating lymphocyte activation. When a relatively similar protocol with only three daily sequential exposures to NO 2 was used a significant decrease in CD4ϩ cells was observed in BAL fluid at a much later time point: 18 h after the last exposure (32) .
In previous studies, the lung matrix component HA was increased in proximal as well as in peripheral airways (19) , but the concentration of HA was unaffected in the present study. Levels of methyl-histamine were also unchanged. Differences in proinflammatory and compensatory mechanisms between the two exposure designs as well as the early time point for bronchoscopy in the present study could account for these different findings.
After the first NO 2 exposure we were able to detect an acute pulmonary response with small, but significant, decrements in both FEV 1 and FVC in healthy subjects. However, after repeated exposures to NO 2 these lung function changes were no longer apparent. This attenuation of lung function response after repeated NO 2 exposure is consistent with the response pattern seen after repeated daily exposure to ozone, where a progressive attenuation of spirometric responses has been reported (35) . Whether repeated exposure to NO 2 at different exposure intervals and concentrations than used in the present study would give rise to different lung function responses is unknown.
With few exceptions, the significant changes detected in this study were with the primary end points, determined a priori, based on preceding studies and upon their biological plausibility. However, in those instances where multiple tests are applied, some caution should always be applied while interpreting the results.
In summary, repeated exposure to NO 2 results in a neutrophilic inflammation in the lower airways that is detectable in the BW. This inflammatory response is not as pronounced as that seen after a single exposure to NO 2 but may still be of importance given the adverse effects by NO 2 on respiratory health as suggested by previous epidemiologic studies. The epithelial lining fluid antioxidant status is not altered by repeated NO 2 exposure, suggesting that the antioxidant responses seen after acute single exposure to NO 2 are accommodated with repeated exposure. Likewise, the acute lung function decrements detected after the first exposure to NO 2 are attenuated with repeated exposures. Taken together, these data indicate that sequential daily exposures to NO 2 result in a number of events that subsequently reduce, but do not abolish, the impact of NO 2 on the lung. It is also evident that there are substantial differences in the airway responses between daily versus alternate-day exposure to NO 2 . Consequently, one must be cautious about drawing definitive conclusions from a single model of repeated NO 2 exposures as many factors, including the number of exposures, duration, and time intervals, are all likely to influence the overall response.
